PROCHLORPERAZINE EDISYLATE
- Product NDC
- 23155-497
- Requested package NDC
- 23155-497-41
- 11-digit product format
- 231550497
- Labeler code
- 23155
- Product ID
- 23155-497_946c01ea-378e-4a97-a646-437b6e61e3a3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PROCHLORPERAZINE EDISYLATE
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Application
- ANDA204147
- Marketing category
- ANDA
- Marketing start
- 2015-01-14
- Marketing end
- 0000-00-00
- Substance
- PROCHLORPERAZINE EDISYLATE
- Active strength
- 5 mg/mL
- Pharmacologic classes
- Phenothiazine [EPC],Phenothiazines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 23155-497 | 23155-497-41 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204147-001 | PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2013-10-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204147-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A204147-001 | PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | INJECTABLE / INJECTION | AP | RS | 2013-10-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A204147-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prochlorperazine Edisylate | PROCHLORPERAZINE EDISYLATE | Cardinal Health 107, LLC | 6135944c-3ee2-4491-9704-33f56ad435f4 | 2025-06-23 | Boxed warning, Warnings, Adverse reactions | 204147 ANDA204147 |
| Prochlorperazine Edisylate | PROCHLORPERAZINE EDISYLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0dc48e66-6081-421b-952b-4867c9c4c794 | 2025-03-11 | Boxed warning, Warnings, Adverse reactions | 204147 ANDA204147 |
| prochlorperazine edisylate | PROCHLORPERAZINE EDISYLATE | Avenacy Inc. | fd07a1a3-c0df-4926-9964-07348e45a5fd | 2024-12-09 | Boxed warning, Warnings, Adverse reactions | 204147 ANDA204147 |
| Prochlorperazine Edisylate | PROCHLORPERAZINE EDISYLATE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 0338b221-db43-45c9-a829-d970fe6643ab | 2024-12-06 | Boxed warning, Warnings, Adverse reactions | 204147 ANDA204147 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 23155-497-31 | ML - Milliliter | 23155-497 | bdfda6ee-4133-4d86-a616-8a1a90151097 | 1 | 2015-07-20 |
| 23155-497-42 | ML - Milliliter | 23155-497 | d7bede80-a5ed-428e-af0f-5860e57d1787 | 1 | 2015-07-20 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| PROCHLORPERAZINE EDISYLATE | ACTIVE INGREDIENT | PG20W5VQZS | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| PROCHLORPERAZINE | ACTIVE MOIETY | YHP6YLT61T | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| SODIUM PHOSPHATE, MONOBASIC | INACTIVE INGREDIENT | 3980JIH2SW | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| SODIUM TARTRATE | INACTIVE INGREDIENT | QTO9JB4MDD | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | PROCHLORPERAZINE EDISYLATE INJECTION [HERITAGE PHARMACEUTICALS INC.] | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 23155-497-41 | 23155049741 | 25 VIAL in 1 PACKAGE (23155-497-41) > 2 mL in 1 VIAL (23155-497-31) | 25 vial | 2015-01-14 | 0000-00-00 | No | No | Current |